| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +25.00% | +4.40% | +0.14% | +4.25% | +4.79% | — |
| 14d | 4 | +50.00% | +2.06% | -1.21% | +3.27% | +6.12% | — |
| 30d | 4 | +100.00% | -7.92% | +0.02% | -7.94% | -4.32% | — |
| 60d | 4 | +50.00% | +77.77% | -1.60% | +79.37% | +82.39% | — |
| 90d | 4 | +50.00% | +106.69% | -3.75% | +110.44% | +113.40% | — |
| 180d | 4(1 pending) | +33.33% | +204.86% | +6.59% | +198.27% | +304.79% | — |
| 1y | 4(3 pending) | +100.00% | -21.83% | +15.76% | -37.59% | -37.59% | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 92,000 | — | — | 92,000 | Mar 19, 2026 | Mar 23, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE See Remarks | 92,000 | — | — | 0 | Mar 19, 2026 | Mar 23, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,150 | — | — | 50,150 | Mar 19, 2026 | Mar 23, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE See Remarks | 50,150 | — | — | 0 | Mar 19, 2026 | Mar 23, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 207,499 | Feb 20, 2026 | Feb 23, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Feb 20, 2026 | Feb 23, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE See Remarks | 6,931 | $1.01 | $7.0K | 152,499 | Jan 6, 2026 | Jan 7, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE See Remarks | 17,923 | $1.00 | $17.9K | 159,430 | Jan 5, 2026 | Jan 7, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE See Remarks | 2,819 | $1.14 | $3.2K | 177,353 | Nov 4, 2025 | Nov 6, 2025 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 58,500 | — | — | 175,172 | Feb 26, 2025 | Feb 28, 2025 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 117,000 | — | — | 117,000 | Feb 26, 2025 | Feb 28, 2025 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE See Remarks | 9,663 | $1.34 | $13.0K | 116,672 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,500 | — | — | 126,335 | Nov 4, 2024 | Nov 5, 2024 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 63,000 | — | — | 63,000 | Nov 4, 2024 | Nov 5, 2024 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 94,833 | Jul 10, 2024 | Jul 12, 2024 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Mar 15, 2024 | Mar 18, 2024 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 32,447 | Mar 15, 2024 | Mar 18, 2024 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 32,447 | Mar 15, 2024 | Mar 29, 2024 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,150 | — | — | 50,150 | Feb 15, 2023 | Feb 17, 2023 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 92,000 | — | — | 92,000 | Oct 14, 2022 | Oct 28, 2022 ↗ | View → |